These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16150050)

  • 1. Cyclooxygenase-1 haplotype modulates platelet response to aspirin.
    Maree AO; Curtin RJ; Chubb A; Dolan C; Cox D; O'Brien J; Crean P; Shields DC; Fitzgerald DJ
    J Thromb Haemost; 2005 Oct; 3(10):2340-5. PubMed ID: 16150050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.
    Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM
    Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin resistance: clinical significance and genetic polymorphism.
    Xu ZH; Jiao JR; Yang R; Luo BY; Wang XF; Wu F
    J Int Med Res; 2012; 40(1):282-92. PubMed ID: 22429367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
    Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
    Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
    Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
    Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease.
    Fan L; Cao J; Liu L; Li X; Hu G; Hu Y; Zhu B
    Gerontology; 2013; 59(2):122-31. PubMed ID: 23038044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
    Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
    Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
    Halushka MK; Walker LP; Halushka PV
    Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity.
    DeFilippis AP; Rai SN; Cambon A; Miles RJ; Jaffe AS; Moser AB; Jones RO; Bolli R; Schulman SP
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):428-33. PubMed ID: 24370448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.